Pfizer could start production in Romania after acquiring a food supplements plant in Cluj

Newsroom 15/02/2011 | 16:13

Pfizer, the world’s biggest pharmaceutical company, could start production in Romania after purchasing the consumer healthcare business of Danish company Ferrosan which owns a food supplement production unit in Cluj. The deal will mark the beginning of Pfizer’s production operations on the local market as until now the American giant imported all the drugs it sells in Romania.

According to Pfizer representatives the deal which is subject to customary closing conditions, including regulatory approval in certain jurisdictions, will be befinalized in the second half of the year but the value of the transaction was not made public.

“Ferrosan is an excellent strategic fit that strengthens our presence in dietary supplements with a new set of compelling brands and product pipeline,” said Paul Sturman, president of Pfizer Consumer Healthcare. “The transaction will mark an important step towards expanding Ferrosan’s brands through Pfizer’s global footprint. As an immediate result of this acquisition, we will gain greater distribution and scale for Pfizer’s well-known brands such as Centrum and Caltrate in Ferrosan’s regions.”